Science
Is Protagonist Therapeutics Inc (NASDAQ: PTGX) Worth It? How Should Investors Deal With It?
During the last session, Protagonist Therapeutics Inc (NASDAQ:PTGX)’s traded shares were 0.66 million, with the beta value of the company hitting 2.33. At the end
